Interaction of prostanoid EP3 and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE2

作者: RL Jones , DF Woodward

DOI: 10.1111/J.1476-5381.2010.01039.X

关键词: ThromboxaneBiologyContraction (grammar)PhenylephrineReceptorEndocrinologyProstanoidInternal medicineAgonistAntagonistProstaglandin E

摘要: BACKGROUND AND PURPOSE Surprisingly high contractile activity was reported for 11-deoxy-16,16-dimethyl prostaglandin E 2 (DX-DM PGE ) on pig cerebral artery when used as a selective EP 3 receptor agonist. This study investigated the selectivity profile of DX-DM , focusing interaction between its and TP (thromboxane A -like) agonist activities. EXPERIMENTAL APPROACH Contraction guinea-pig trachea (EP 1 system) aorta systems) measured in conventional organ baths. KEY RESULTS Strong contraction to sulprostone 17-phenyl agonists) only seen under priming with second agent such phenylephrine, histamine or U-46619 (TP agonist). In contrast, induced strong contraction, which basis treatment (DG)-3ap antagonist) and/or BMS-180291 attributed self-synergism arising from co-activation receptors. 3/ also accounted by PGF 2α analogues (+)-cloprostenol latanoprost-FA. showed significant agonism defined antagonists SC-51322, (ONO)-5-methyl-1 AH-6809, although AH-6809 exhibited poor specificity at concentrations ≥ μM. CONCLUSIONS IMPLICATIONS self-synergism, PGE/PGF this study, may confound potency comparisons characterization prostanoid systems. The competitive antagonist be distorted variation silent/overt system different studies. relevance vivo actions natural agonists is discussed.

参考文章(50)
Rongan Zhang, Martin L. Ogletree, Suzanne Moreland, Characterization of thromboxane A2/prostaglandin endoperoxide receptors in aorta European Journal of Pharmacology. ,vol. 317, pp. 91- 96 ,(1996) , 10.1016/S0014-2999(96)00697-8
J. L. Walker, D. P. Tuffin, A. K. Banerjee, Pharmacological effects of (+/-)-11-deoxy, 16-phenoxy-prostaglandin E1 derivatives in the cardiovascular system. British Journal of Pharmacology. ,vol. 84, pp. 71- 80 ,(1985)
RL Jones, DF Woodward, JW Wang, RL Clark, Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations British Journal of Pharmacology. ,vol. 162, pp. 863- 879 ,(2011) , 10.1111/J.1476-5381.2010.01087.X
J. Y. Crider, G. W. Williams, B. W. Griffin, N. A. Sharif, T. L. Davis, S. X. Xu, Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. Journal of Pharmacology and Experimental Therapeutics. ,vol. 286, pp. 1094- 1102 ,(1998)
R Håkanson, E Ekblad, L Edvinsson, C Wahlestedt, Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. Journal of Pharmacology and Experimental Therapeutics. ,vol. 234, pp. 735- 741 ,(1985)
P Leff, An analysis of amplifying and potentiating interactions between agonists. Journal of Pharmacology and Experimental Therapeutics. ,vol. 243, pp. 1035- 1042 ,(1987)
G L Stupecky, D L Murray, R E Purdy, Vasoconstrictor threshold synergism and potentiation in the rabbit isolated thoracic aorta. Journal of Pharmacology and Experimental Therapeutics. ,vol. 238, pp. 802- 808 ,(1986)
Ruth A. Lawrence, R.L. Jones, N.H. Wilson, Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea‐pig ileum British Journal of Pharmacology. ,vol. 105, pp. 271- 278 ,(1992) , 10.1111/J.1476-5381.1992.TB14245.X
Jinshan Cao, Mikeremu Shayibuzhati, Tsuyoshi Tajima, Takio Kitazawa, Tetsuro Taneike, In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium European Journal of Pharmacology. ,vol. 442, pp. 115- 123 ,(2002) , 10.1016/S0014-2999(02)01489-9